Sep 01, 2015 at 20:48 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals at its meeting held on September 01, 2015, has considered the resignation of Mr. Arvind Kumar Bhangadia from the position of Managing director. However the board has accepted the resignation and requested him to continue till the appointment of new Managing director.
Sep 01, 2015 at 10:01 | Source: Moneycontrol.com
"Sun Pharma today begins the integration of its Opiates business in Australia following the successful completion of this acquisition from GSK (announced in March 2015)," said the country's largest drug maker in its filing.
Aug 31, 2015 at 11:04 | Source: Moneycontrol.com
Broking house Angel Broking has maintained accumulate rating on the stock with a target of Rs 872.
Aug 31, 2015 at 09:39 | Source: Moneycontrol.com
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Raloxifene Hydrochloride Tablets USP 60mg (ANDA 204310).
Aug 30, 2015 at 13:53 | Source: PTI
According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.
Aug 29, 2015 at 15:46 | Source: PTI
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
Aug 28, 2015 at 12:57 | Source: PTI
The shares opened on a bullish note at Rs 673.25 and jumped 2.81 percent to an early high of Rs 679.75
Aug 27, 2015 at 20:53 | Source: PTI
Cipla is having presence in over 150 countries, manufacture drugs in over 50 dosages and has a portfolio in excess of 1,500 products.
Aug 27, 2015 at 18:01 | Source: PTI
The company has received final approval for its Omeprazole delayed-release capsules (40 mg) from the United States Food and Drugs Administration (USFDA), Lupin Ltd said in a statement.
Aug 27, 2015 at 13:39 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0.5mg and 1mg, Aurobindo Pharma said in a statement.